Better measures. More power. Fewer patients.
Our technology is improving compliance, patient experience and effect detection in clinical studies
 

Remote continuous monitoring using clinically validated biometric wearable devices in clinical research
Remote continuous monitoring using clinically validated biometric wearable devices in clinical research


Study Design

We collaborate with our partners to take advantage of new technology to better characterize disease burden or improve the power to detect treatment effects.


Real World Data Integration

Our software enables integration of patient generated data via mobile devices, remote biometrics, and digital health tools in compliance with industry standards and regulations.


Analytics Platform

Our analytics platform has the ability to aggregate, link, monitor and analyze continuous and high volume data sources that are not supported by traditional clinical trial systems or analysis packages.

REAL WORLD CLINICAL DATA PLATFORM

 
Koneksa clinical trial monitoring software to capture biometric wearable device data
 
 

Capture, monitor and analyze patient generated data and outcomes in clinical studies.


115,000

Data Points Measured

189,000

Megabytes of Subject Data


PRESS RELEASE

Tracking Physical Activity of Cancer Patients to Avoid Unplanned Hospitalization

Today, Koneksa Health, an early stage company focused on the integration of real world data into clinical research, announced a research project using Garmin vivofit® devices to track the activity of cancer patients during concurrent chemo-radiotherapy.

Continue reading  ›

NEWS

ActiGraph Launches CentrePoint Toolkit to Provide Technology Framework for Home-­based Healthcare Solutions

Pensacola, FL – Nov 15, 2016 -­ ActiGraph, a leading provider of clinical-­grade wearable activity and sleep monitoring solutions, has announced the launch of the CentrePoint technology toolkit, which enables clients to  ...

Continue reading 

PRESS RELEASE

Takeda and Koneksa Health Announce Strategic Collaboration to Use Digital Health Tools in Clinical Trials

Cambridge, Mass. , and New York, NY, USA,  November 7, 2016 – Takeda Pharmaceutical Company Limited (TSE: 4502) (“Takeda”) and Koneksa Health, Inc. (“Koneksa”), an early stage company focused on the integration of real ...

Continue reading  ›